• MGI Announces April Availability Of Sequencers, Reagents In US

    Bio-IT World MGI, part of global genomics leader BGI Group, announced the commercial availability of its sequencing instruments and reagent kits in the United States based on MGI’s own innovative CoolMPS sequencing chemistry, starting in April of this year.

    Feb 21, 2020

  • The Value Of Imaging Data As The Missing Essential Component Of Real World Data

    Bio-IT World Contributed Commentary | Radiology is increasingly the key to synthesizing real world evidence with sufficient quality to shape drug performance. As a diagnostic toolset, imaging is one of the oldest and most widely used and clearly interpreted methods for measurement of outcomes. It is regularly used to measure disease progression and to determine the effectiveness of medical interventions. Imaging is also a common mechanism for early identification of disease that can be automated or extended through artificial intelligence (AI).

    Feb 20, 2020

  • Follow the Money: Big Investments In CRISPR, Cell Therapies, Health Data Management

    Bio-IT World | Some big investments are driving CRISPR-based therapeutics, cell therapies, sepsis diagnostics and more this year. Unspecified investments by pharma are further propelling Seqster’s health data management platform.

    Feb 19, 2020

  • 2020 Open Access Award Finalists Named

    Bio-IT World Bioinformatics.org today announced the finalists in the 2020 Benjamin Franklin Award for Open Access in the Life Sciences. Voting is open to Bioinformatics.org members, and will be open until Friday, February 28. The winner will be announced at the 2020 Bio-IT World Conference & Expo.

    Feb 17, 2020